Personalized medicine
-
DATABASE (52)
-
ARTICLES (97)
CSO and co-founder of iLoF
Paula Sampaio is a biochemist who completed a PhD in biomedical sciences at the University of Porto in 1998. She worked as a postdoctoral research fellow at the IMBC INEB Associate Laboratory for four years. In 2002, she was promoted to the role of head of advanced light microscopy and stayed there until 2015. Sampaio is now the national coordinator for Portuguese bioimage platform PPBI and the head of advanced light microscopy at the Institute of Research and Innovation of the University of Porto (i3S).In November 2019, she joined iLoF as CSO and co-founder. iLoF gets technical support from i3S at the R&D center in Porto. The medtech startup focuses on personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to gather and manages disease biomarkers and biological profiles.
Paula Sampaio is a biochemist who completed a PhD in biomedical sciences at the University of Porto in 1998. She worked as a postdoctoral research fellow at the IMBC INEB Associate Laboratory for four years. In 2002, she was promoted to the role of head of advanced light microscopy and stayed there until 2015. Sampaio is now the national coordinator for Portuguese bioimage platform PPBI and the head of advanced light microscopy at the Institute of Research and Innovation of the University of Porto (i3S).In November 2019, she joined iLoF as CSO and co-founder. iLoF gets technical support from i3S at the R&D center in Porto. The medtech startup focuses on personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to gather and manages disease biomarkers and biological profiles.
CTO and co-founder of iLoF
Joana Paiva graduated in 2014 with a master’s in biomedical engineering at the University of Coimbra in Portugal. She went on to complete a PhD in physics at the University of Porto in 2019.In 2014, she also worked at INESC Technology and Science for almost five years while completing her PhD thesis: Intelligent Lab on Fiber tools for sensing single-cells and extracellular nano-vesicles. It was her research that led to the founding of medtech startup iLoF.In August 2019, she co-founded iLoF as CTO. The Oxford-Oporto-based startup enables personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to collate disease biomarkers and biological profiles.Based in Porto, she is also a co-inventor with three patents and 29 scientific publications. She is one of Forbes 30 Under 30 for science and healthcare and was nominated for the EIT Woman Award 2020.
Joana Paiva graduated in 2014 with a master’s in biomedical engineering at the University of Coimbra in Portugal. She went on to complete a PhD in physics at the University of Porto in 2019.In 2014, she also worked at INESC Technology and Science for almost five years while completing her PhD thesis: Intelligent Lab on Fiber tools for sensing single-cells and extracellular nano-vesicles. It was her research that led to the founding of medtech startup iLoF.In August 2019, she co-founded iLoF as CTO. The Oxford-Oporto-based startup enables personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to collate disease biomarkers and biological profiles.Based in Porto, she is also a co-inventor with three patents and 29 scientific publications. She is one of Forbes 30 Under 30 for science and healthcare and was nominated for the EIT Woman Award 2020.
Co-founder of Therapixal
Olivier Clatz is the French co-founder of AI medical diagnosis company Therapixel, creator of MammoScreen breast cancer screening and diagnosis tool. Prior to co-founding Therapixel, Clatz worked for six years as a research scientist at INRIA (National Institute for Research in Digital Science and Technology) based at the Sophia Antipolis technology park near Antibes, in the south of France. His later work with INRIA focused on exploiting machine learning algorithms for medical imaging processing. Prior to this, he was a research associate at Harvard Medical School, in the US. In 2006, he completed his PhD at INRIA on the concept of personalized medicine. Clatz also holds a PhD in philosophy from the Ecole des Mines de Paris, and a master's degree in applied mathematics from the Ecole Normale Supérieure Paris-Saclay. Currently, he works at the French Government’s Commissariat Générale pour l’Investissement managing the national program AI For Diagnostics. He left Therapixel in 2019.
Olivier Clatz is the French co-founder of AI medical diagnosis company Therapixel, creator of MammoScreen breast cancer screening and diagnosis tool. Prior to co-founding Therapixel, Clatz worked for six years as a research scientist at INRIA (National Institute for Research in Digital Science and Technology) based at the Sophia Antipolis technology park near Antibes, in the south of France. His later work with INRIA focused on exploiting machine learning algorithms for medical imaging processing. Prior to this, he was a research associate at Harvard Medical School, in the US. In 2006, he completed his PhD at INRIA on the concept of personalized medicine. Clatz also holds a PhD in philosophy from the Ecole des Mines de Paris, and a master's degree in applied mathematics from the Ecole Normale Supérieure Paris-Saclay. Currently, he works at the French Government’s Commissariat Générale pour l’Investissement managing the national program AI For Diagnostics. He left Therapixel in 2019.
Co-founder and CTO of Worktile
Li earned his master’s degree in Software Engineering from Nankai University. He won the Microsoft Most Valuable Professional award four years in a row starting in 2007. From 2009 to 2011, Li was in charge of system architecture design at Fetion, an instant messaging tool developer. In 2011, he co-founded a startup that provided personalized reading recommendations, but it failed after eight months. Li co-founded Worktile with Wang Tao in late 2012.
Li earned his master’s degree in Software Engineering from Nankai University. He won the Microsoft Most Valuable Professional award four years in a row starting in 2007. From 2009 to 2011, Li was in charge of system architecture design at Fetion, an instant messaging tool developer. In 2011, he co-founded a startup that provided personalized reading recommendations, but it failed after eight months. Li co-founded Worktile with Wang Tao in late 2012.
Co-founder, CEO of UTW (Unmanned Technical Works)
Julio Díaz Hernández worked as an electrical engineer for Spain's ITP group for two years before joining aerospace manufacturer ITD in 2001. He became ITD's head of systems design business unit based at Getafe before leaving in 2015 to become the co-founder and CEO of Unmanned Technical Works (UTW).The MBA postgrad, mechanical engineering and industrial electronics alumnus from Madrid's Polytechnic University also co-founded Aventix as CEO. Aventix provides personalized engineering services to UTW and other clients in the aerospace, ICT, railway, automotive and energy sectors.
Julio Díaz Hernández worked as an electrical engineer for Spain's ITP group for two years before joining aerospace manufacturer ITD in 2001. He became ITD's head of systems design business unit based at Getafe before leaving in 2015 to become the co-founder and CEO of Unmanned Technical Works (UTW).The MBA postgrad, mechanical engineering and industrial electronics alumnus from Madrid's Polytechnic University also co-founded Aventix as CEO. Aventix provides personalized engineering services to UTW and other clients in the aerospace, ICT, railway, automotive and energy sectors.
COO and co-founder of iLoF
Mehak Mumtaz grew up in Pakistan and decided to study biochemistry when she saw her brother suffering from an unknown learning disability. Her parents, both medical doctors, could not get an accurate diagnosis for their son. In her search to understand the molecular mechanisms behind diseases, she applied to study at the University of Oxford. In 2008, she was granted the Reach Oxford Scholarship and graduated with a master’s in biochemistry in 2012. In 2015, the St Hilda’s alumna worked as an undergraduate tutor at Oxford while completing a PhD in pathology, specializing in oncology and cancer biology.In 2018, she worked on a rare cancer project as EIT Health Business Innovation fellow for a year. She left academia and joined a three-month bioentrepreneur bootcamp in Munich and a one-month Lev8 Woman Program at her alma mater’s Oxford Foundry. She joined EY-Parthenon in London as a strategy consultant in April 2019.In 2019, Mumtaz also met the iLoF co-founding team at the EIT Health Wild Card venture-building program. iLoF is a medtech startup that focuses on personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to gather and manages disease biomarkers and biological profiles.She joined iLoF as COO and co-founder in December 2019 and left her full-time consultancy role at EY in March 2020.
Mehak Mumtaz grew up in Pakistan and decided to study biochemistry when she saw her brother suffering from an unknown learning disability. Her parents, both medical doctors, could not get an accurate diagnosis for their son. In her search to understand the molecular mechanisms behind diseases, she applied to study at the University of Oxford. In 2008, she was granted the Reach Oxford Scholarship and graduated with a master’s in biochemistry in 2012. In 2015, the St Hilda’s alumna worked as an undergraduate tutor at Oxford while completing a PhD in pathology, specializing in oncology and cancer biology.In 2018, she worked on a rare cancer project as EIT Health Business Innovation fellow for a year. She left academia and joined a three-month bioentrepreneur bootcamp in Munich and a one-month Lev8 Woman Program at her alma mater’s Oxford Foundry. She joined EY-Parthenon in London as a strategy consultant in April 2019.In 2019, Mumtaz also met the iLoF co-founding team at the EIT Health Wild Card venture-building program. iLoF is a medtech startup that focuses on personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to gather and manages disease biomarkers and biological profiles.She joined iLoF as COO and co-founder in December 2019 and left her full-time consultancy role at EY in March 2020.
Kingfisher is a privately owned, and independently managed financial services firm active for nearly three decades. The firm was established in Charlotte in the US in 1989 and acquired by WealthTrust, LLC in 2004. In 2009, it returned to operate as an independent investment adviser under the name of Kingfisher Capital, LLC and purchased all outstanding ownership interest from WealthTrust LLC. Kingfisher has supported affluent families, professionals, business owners, and institutions through financial advisory, smart investments and personalized client service.The firm is currently led by managing partners and co-founders Alexander Miles and H K Hallett. Prior to founding Kingfisher, Miles worked at WealthTrust Advisors, the Myers Limited Partnerships and Lehman Brothers in New York. Hallett worked for Trust Company Bank of Georgia and Peoples Bank of North Carolina before joining Carolina Securities Corporation, where he co-managed the Charlotte office.
Kingfisher is a privately owned, and independently managed financial services firm active for nearly three decades. The firm was established in Charlotte in the US in 1989 and acquired by WealthTrust, LLC in 2004. In 2009, it returned to operate as an independent investment adviser under the name of Kingfisher Capital, LLC and purchased all outstanding ownership interest from WealthTrust LLC. Kingfisher has supported affluent families, professionals, business owners, and institutions through financial advisory, smart investments and personalized client service.The firm is currently led by managing partners and co-founders Alexander Miles and H K Hallett. Prior to founding Kingfisher, Miles worked at WealthTrust Advisors, the Myers Limited Partnerships and Lehman Brothers in New York. Hallett worked for Trust Company Bank of Georgia and Peoples Bank of North Carolina before joining Carolina Securities Corporation, where he co-managed the Charlotte office.
One of China’s biggest medicine delivery unicorns, Dingdang offers 24/7 AI-robo service and consultation, offline smart pharmacies, and delivery in under 30 minutes.
One of China’s biggest medicine delivery unicorns, Dingdang offers 24/7 AI-robo service and consultation, offline smart pharmacies, and delivery in under 30 minutes.
Mayfield Fund is one of Silicon Valley's oldest venture capital firms. Founded by Wally Davis and Thomas J Davis Jr in 1969, the VC is based in Menlo Park, California.Current investments include CRISPR-focused companies like Mammoth Biosciences and biotech startup iLoF,l which is focused on creating a digital library of optical fingerprints for non-invasive patient screening, early diagnostics and personalized medical treatments.. With a total of $2.5bn assets under management, the firm focuses mainly on early-stage to growth-stage investments. The VC has also backed startups like Marketo, Lyft and SolarCity. Most of Mayfield’s exits took place during the 2008 financial crisis and through subsequent funds.In April 2020, amid the Covid-19 pandemic, Mayfield announced two new funds which raised $750m in total. Mayfield XVI will invest in early-stage companies, while Mayfield Select II will focus on growth-stage companies outside its portfolio. The company said last year that it has raised a similar size fund every four years and has invested in 30 companies per fund. It primarily leads Series A investments.
Mayfield Fund is one of Silicon Valley's oldest venture capital firms. Founded by Wally Davis and Thomas J Davis Jr in 1969, the VC is based in Menlo Park, California.Current investments include CRISPR-focused companies like Mammoth Biosciences and biotech startup iLoF,l which is focused on creating a digital library of optical fingerprints for non-invasive patient screening, early diagnostics and personalized medical treatments.. With a total of $2.5bn assets under management, the firm focuses mainly on early-stage to growth-stage investments. The VC has also backed startups like Marketo, Lyft and SolarCity. Most of Mayfield’s exits took place during the 2008 financial crisis and through subsequent funds.In April 2020, amid the Covid-19 pandemic, Mayfield announced two new funds which raised $750m in total. Mayfield XVI will invest in early-stage companies, while Mayfield Select II will focus on growth-stage companies outside its portfolio. The company said last year that it has raised a similar size fund every four years and has invested in 30 companies per fund. It primarily leads Series A investments.
Founded in 2014, Prosperico Ventures targets the healthcare sector. The VC has invested in nearly 30 startups working on medical devices, pharmaceutical R&D, provision of medical services and precision medicine.
Founded in 2014, Prosperico Ventures targets the healthcare sector. The VC has invested in nearly 30 startups working on medical devices, pharmaceutical R&D, provision of medical services and precision medicine.
CMO and co-founder of Biel Glasses
Since 2017, Constanza Lucero has been the co-founder and Chief Medical Officer at Biel Glasses, a medtech startup offering relief to people with low vision. She is the mother of Biel, who was born with low vision and the impetus for the startup. She also works at Badalona Hospital as a Specialist in Internal Medicine in its Accidents and Emergencies Department. Prior to this, she worked for nine years at Barcelona's Hospital Clinic as a Specialist in Infectious Diseases, HIV and Internal Medicine. Lucero holds a Doctorate of Medicine from the University of Barcelona as well as a master's in Clinical Research from the same institution.
Since 2017, Constanza Lucero has been the co-founder and Chief Medical Officer at Biel Glasses, a medtech startup offering relief to people with low vision. She is the mother of Biel, who was born with low vision and the impetus for the startup. She also works at Badalona Hospital as a Specialist in Internal Medicine in its Accidents and Emergencies Department. Prior to this, she worked for nine years at Barcelona's Hospital Clinic as a Specialist in Infectious Diseases, HIV and Internal Medicine. Lucero holds a Doctorate of Medicine from the University of Barcelona as well as a master's in Clinical Research from the same institution.
Founded in Shenzhen in 2013, Topsailing Capital is mainly involved in venture capital and private equity funding of diverse industry sectors like culture, entertainment, big data, intelligent manufacturing, agriculture, environmental protection and medicine.
Founded in Shenzhen in 2013, Topsailing Capital is mainly involved in venture capital and private equity funding of diverse industry sectors like culture, entertainment, big data, intelligent manufacturing, agriculture, environmental protection and medicine.
Co-founder and CEO of Zhuojian
Undergrad medicine, Zhejiang University; PhD, Medical University of South Carolina. Former surgeon at First Affiliated Hospital of Zhejiang University.
Undergrad medicine, Zhejiang University; PhD, Medical University of South Carolina. Former surgeon at First Affiliated Hospital of Zhejiang University.
Founder and CEO of Halodoc
Jonathan Sudharta is the son of Sudharta, the founder of pharmaceutical conglomerate Mensa Group. He graduated from Curtin University, Australia with a bachelor's in Economics, specializing in electronic commerce. Jonathan has since helped to expand his family business, building a social media network for doctors and developing ApotikAntar, a service for delivering medicine from licensed pharmacies to customers. In 2016, he combined the medicine delivery service and online interaction with doctors to create Halodoc, a healthcare platform startup backed by the Mensa Group.
Jonathan Sudharta is the son of Sudharta, the founder of pharmaceutical conglomerate Mensa Group. He graduated from Curtin University, Australia with a bachelor's in Economics, specializing in electronic commerce. Jonathan has since helped to expand his family business, building a social media network for doctors and developing ApotikAntar, a service for delivering medicine from licensed pharmacies to customers. In 2016, he combined the medicine delivery service and online interaction with doctors to create Halodoc, a healthcare platform startup backed by the Mensa Group.
Founded in Silicon Valley by serial investor and founder of Google Ventures Bill Marris, Section 32 has multiple investment interests with medicine and biotech key amongst them. Marris himself has invested in over 500 companies, with over one-third resulting in IPO or M&A. Fifty of his portfolio companies have exceeded $1bn valuations, including Uber. Section 32 currently has 48 companies in its portfolio. Its most recent investments have included in Canadian remote medicine platform Cover Health’s $43m Series B round and in the $100m Series B round of US cancer detection software C2i Genomics, both in April 2021. In March 2021, it participated in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Founded in Silicon Valley by serial investor and founder of Google Ventures Bill Marris, Section 32 has multiple investment interests with medicine and biotech key amongst them. Marris himself has invested in over 500 companies, with over one-third resulting in IPO or M&A. Fifty of his portfolio companies have exceeded $1bn valuations, including Uber. Section 32 currently has 48 companies in its portfolio. Its most recent investments have included in Canadian remote medicine platform Cover Health’s $43m Series B round and in the $100m Series B round of US cancer detection software C2i Genomics, both in April 2021. In March 2021, it participated in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Allozymes wants to supercharge manufacturing with engineered enzymes
The Future Food Asia 2021 award winner speeds up enzyme engineering from years to months, is already attracting clients and has just raised $5m seed funding
Dao Foods unfazed by China tech crackdown, says alternative proteins aligned with state goals
Impact investor Dao Foods expects government support for alternative proteins to come, as it announces second batch of startups, diversifying into fermentation and cell-based proteins
Xhockware's YouBeep app for speedy checkout, higher customer spending
Besides cutting checkout time to under 1 minute, this in-store shopping app also has other bright ideas: targeted marketing, allergy warnings, even wine-pairing tips
Geometry Healthcare: Smart toilets that warn you if you are sick, or at risk
Using a biochip for urinalysis and offline health management services, Geometry Healthcare aims to differentiate itself in the smart toilet business
Trudy Dai: Alibaba’s jane of all trades
Dai has played a pivotal role in the success of the world’s biggest e-commerce platform; now the tech giant is trusting her to run its VC arm
WOOM: Spanish fertility femtech gets €2m funding to expand into new B2B2C markets
AI fertility app WOOM has also created an English-language version to reach more users in North America, Europe and Asia
Keep: Social fitness app bags $80m Series E as Covid-19 lockdown fuels demand for virtual gyms
Keep becomes China’s first sports tech unicorn as number of fitness app users in the country almost doubled to 89m amid home confinement and gym closures
East Ventures raises funds, teams up with state agency to produce Covid-19 tests for Indonesia
East Ventures investee Nusantics has been working with state researchers to produce the prototype; expects mass production of the test kits soon
Coronavirus: Portuguese startups pitch in as nation battles pandemic
More than 120 startups join the #tech4COVID19 initiative, offering the public free medical help, meals for the vulnerable, online education and more
DORM: New-generation housing for Indonesia’s tech-savvy, community-driven students
Combining online features with offline services, DORM goes way beyond what the market typically offers in student accommodation
HigoSense launching advanced mobile device for self-triage and diagnosis, boosting telemedicine
The Polish medtech has developed a five-in-one diagnostic device for throat, ear, heart checks and more, with diagnosis in four minutes and compatible with diagnostic equipment
Meatable: Cell-based meat startup secures $47m Series A for scalable technology
The Dutch startup offers a pioneering technology for quickly scaling cell-based meat production while eliminating the need for animal-derived growth media
South Summit 2021: Martin Varavsky, Leandro Sigman on post-Covid healthcare trends
Serial entrepreneur Martin Varavsky and Insud Pharma Chairman Leandro Sigman share their thoughts and projections on the future of health tech
Promising market, but China’s DTC genetic testing startups have to first overcome a few hurdles
Genetic information is being used for everything from predicting health risks to personalizing exercise and dietary regimes. China represents a huge potential market for direct-to-consumer (DTC) genetic testing
Raw Data: Bringing new predictability to harvests
Spanish ML, big data startup helps farmers perfect wine and fruit production in a fast-growing precision agtech sector
Sorry, we couldn’t find any matches for “Personalized medicine”.
